Halitosis Treatment Market: Rising Prevalence of Periodontal Diseases to Drive the Market

According to the American Dental Association, halitosis is a ‘chronic bad breath’, it is a clinical condition characterized by unpleasant smell present in the mouth, which is detectable by other people.

According to the American Dental Association (ADA), halitosis is a ‘chronic bad breath’, it is a clinical condition characterized by unpleasant smell present in the mouth, which is detectable by other people. It can be caused due to various reasons such as medication, diet, poor oral hygiene, and diseases or conditions such as diabetes, lactose intolerance, GERD, and gum diseases.

Read Report Overview - https://www.transparencymarketresearch.com/halitosis-treatment-market.html

Bad breath is a major problem across the globe, which affects the social life of several people. It may lead to stress and psychological pressure, further affecting a person’s life. A wide range of oral care products are available for the treatment of halitosis. Major market players are engaged in the manufacturing of oral care products in different flavors.

The global halitosis treatment market is anticipated to expand at a considerable pace due to the rise in geriatric population and increase in prevalence of chronic diseases. The market is driven by rising prevalence of periodontal diseases. Moreover, the market is expected to be driven by surge in initiatives by various government agencies and technological advancements. However, lack of awareness about halitosis and its treatment is projected to hinder the global market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50301

The global halitosis treatment market is segmented based on type, indication, diagnostic test, drug treatment, and geography. In terms of type, the market can be bifurcated into pathological halitosis and physiological halitosis. Based on indication, the halitosis treatment market can be segregated into respiratory, kidney, gastrointestinal, liver, systemic, and others. The respiratory segment can be further classified into sinusitis, emphysema, pharyngitis, tuberculosis, pneumonia, and others. The liver segment can be sub-segmented into gall bladder diseases, liver failure, and others.

The gastrointestinal segment is further categorized into stomach cancer, esophageal reflux, malabsorption, and pharyngitis. In terms of diagnostic test, the halitosis treatment market can be divided into gas chromatography, halimeter, β-galactosidase activity assay, BANA test, and others. Based on drug treatment, the global market can be classified into antiseptics, antacids, ranitidine, and others. The others segment includes drugs such as cimetidine and cetylpyridinium chloride.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=50301

In terms of region, the global halitosis treatment market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is sub-segmented into countries such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC countries. North America dominated the global halitosis treatment market due to growth in geriatric population and increase in demand for innovative medical technology.

Additionally, rise in prevalence of gum diseases and extensive use of oral care products such as mouth washes, toothpastes, and mouth sprays. In 2013, US$ 810 Mn was spent on the treatment of halitosis in the U.S. Asia Pacific is projected to be a lucrative region for the market during the forecast period due to rise in prevalence of chronic diseases, such as diabetes, kidney or liver failure, respiratory diseases, and increase in population. Surge in geriatric population suffering from these diseases is expected to boost the market.

Pre Book Halitosis Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=50301&ltype=S

Key players operating in the global halitosis treatment market include Colgate-Palmolive Company, All USA Partners LLC, Dr. Harold Katz, LLC, Rowpar Pharmaceuticals, Inc., Abbott, Listerine, and AstraZeneca. These players actively engage in various growth strategies, such as collaborations, agreements, partnerships, and launch of new products, to gain a competitive advantage in the market.

Browse more Reports by Transparency Market Research:

Clinical Trials Market: According to Transparency Market Research’s latest report on the global clinical trials market for the historical period 2018–2019 and forecast period 2020–2030, high prevalence and increase in incidence rate of chronic diseases and rise in R&D activities in biotechnology & pharmaceuticals industries are projected to drive the global clinical trials market during the forecast period.

Radiation Dermatitis Market: According to Transparency Market Research’s latest report on the global radiation dermatitis market for the historical year 2018 and forecast period 2020-2030, rise in prevalence of cancer and increase in adoption of radiation therapy for cancer treatment are projected to drive the global radiation dermatitis market during the forecast period

Lyophilized Injectable Market: Lyophilization is the most commonly used method for the manufacturing of parenteral pharmaceutical products, when the product is unstable in aqueous solution. It is central to the protection of materials, which require low moisture content (less than 1%) in order to ensure stability and require a sterile and gentle preservation process.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/